Novel Cu(II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains

Concerns on increasing trends of multidrug resistance (MDR) around the world have triggered the need to investigate and develop new therapeutic strategies and potent antibacterial drugs. Polymyxins, a class of polycationic antimicrobial peptides, have been regarded as the last-line therapy against G...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of peptide research and therapeutics 2022-03, Vol.28 (2), Article 60
Hauptverfasser: Gan, Wei Khang, Liew, Hui Shan, Pua, Lesley Jia Wei, Ng, Xiao Ying, Fong, Kar Wai, Cheong, Siew Lee, Liew, Yun Khoon, Low, May Lee
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page
container_title International journal of peptide research and therapeutics
container_volume 28
creator Gan, Wei Khang
Liew, Hui Shan
Pua, Lesley Jia Wei
Ng, Xiao Ying
Fong, Kar Wai
Cheong, Siew Lee
Liew, Yun Khoon
Low, May Lee
description Concerns on increasing trends of multidrug resistance (MDR) around the world have triggered the need to investigate and develop new therapeutic strategies and potent antibacterial drugs. Polymyxins, a class of polycationic antimicrobial peptides, have been regarded as the last-line therapy against Gram-negative bacteria due to limited new antibiotics and phenylalanine-arginine β-naphthylamide (PAβN), a peptidomimetic compound has been characterised as an efflux pump inhibitor (EPI) that have been investigated to overcome efflux-mediated multidrug resistance. In this work, the antibacterial activity of two Schiff base ligands derived from the condensation of S-benzyl dithiocarbazate with 4-carboxybenzaldehye (SB4CB) and 4-formyl-3-hydroxybenzoic acid (SBFH) their copper(II) complexes (Cu(SB4CB) 2 and Cu(SBFH) 2 ) were tested individually, and the most promising compound was tested in combination with polymyxin B (POLY) and PAβN against different bacteria, such as antibiotic-susceptible strains: Acinetobacter baumannii ATCC 19606, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 35923; multidrug-resistant strains: A. baumannii ATCC BAA-1797, E. coli BAA-196, P. aeruginosa ATCC BAA-2108 and S. aureus ATCC 43300. Initial minimum inhibition concentration (MIC) results showed the Cu(II) complexes Cu(SB4CB) 2 and Cu(SBFH) 2 , demonstrated obvious antibacterial activity as compared to the ligand alone. Fractional inhibitory concentration (FIC) index showed improved MIC values with additivity and synergistic effect for Cu(SBFH) 2 in combination with POLY and PAβN. From the in silico molecular docking investigation, Cu(SBFH) 2 was shown to engage in hydrophobic interactions via its phenyl rings with surrounding hydrophobic residues in the binding pocket of S. aureus NorA, E. coli AcrB, P. aeruginosa MexB and A. baumannii AdeB efflux pumps. The phenyl rings of the ligand could also form π-π stacking with adjacent residues in the binding site of A. baumannii AdeB. Besides, hydrogen bonding and π-cation interactions were also observed via the carboxyl group, hydroxyl group and phenyl ring of SBFH moiety, respectively with nearby residues in the E. coli AcrB binding pocket. This study indicates that the combination strategy of Cu(SBFH) 2 with POLY and PAβN enhances therapeutic potential and sheds light on the binding pockets inside bacteria efflux pumps and the binding interactions of ligand in the binding site.
doi_str_mv 10.1007/s10989-021-10358-x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2622678067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2622678067</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319t-de40c4dabdef4cf40e1ae15209126854d72a0c0d48270d0708d5748585c3c04a3</originalsourceid><addsrcrecordid>eNp9UN1OwjAYXYwmIvoCXjXxRi8qX7uObpdA_CEhSIJ625SuYyWjw3YoewLfxwfxmRxO451X5yTnLzlBcE7gmgDwnieQxAkGSjCBMIrx7iDokIiHOEyAHf5ywpLj4MT7FUBEOYFO8D4tX3WBRtvL8fgKzVVusgwNpddoVK43hd7tcWGsrExp0ZupcjQri3pd74xFw94s17YuZCGtsRoP3NLsCfr8wFO5yau80dYm1WiwlMb6Cj1LZ8qtbxZUpZ2RBZpXbi-dBkeZLLw--8Fu8HR78zi6x5OHu_FoMMEqJEmFU81AsVQuUp0xlTHQRGoSUUgI7ccRSzmVoCBlMeWQAoc4jTiLozhSoQImw25w0fZuXPmy1b4Sq3LrbDMpaJ_SPo-hzxsXbV3Kld47nYmNM2vpakFA7A8X7eGiOVx8Hy52TShsQ74x26V2f9X_pL4AM-SFzA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2622678067</pqid></control><display><type>article</type><title>Novel Cu(II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains</title><source>SpringerLink Journals - AutoHoldings</source><creator>Gan, Wei Khang ; Liew, Hui Shan ; Pua, Lesley Jia Wei ; Ng, Xiao Ying ; Fong, Kar Wai ; Cheong, Siew Lee ; Liew, Yun Khoon ; Low, May Lee</creator><creatorcontrib>Gan, Wei Khang ; Liew, Hui Shan ; Pua, Lesley Jia Wei ; Ng, Xiao Ying ; Fong, Kar Wai ; Cheong, Siew Lee ; Liew, Yun Khoon ; Low, May Lee</creatorcontrib><description>Concerns on increasing trends of multidrug resistance (MDR) around the world have triggered the need to investigate and develop new therapeutic strategies and potent antibacterial drugs. Polymyxins, a class of polycationic antimicrobial peptides, have been regarded as the last-line therapy against Gram-negative bacteria due to limited new antibiotics and phenylalanine-arginine β-naphthylamide (PAβN), a peptidomimetic compound has been characterised as an efflux pump inhibitor (EPI) that have been investigated to overcome efflux-mediated multidrug resistance. In this work, the antibacterial activity of two Schiff base ligands derived from the condensation of S-benzyl dithiocarbazate with 4-carboxybenzaldehye (SB4CB) and 4-formyl-3-hydroxybenzoic acid (SBFH) their copper(II) complexes (Cu(SB4CB) 2 and Cu(SBFH) 2 ) were tested individually, and the most promising compound was tested in combination with polymyxin B (POLY) and PAβN against different bacteria, such as antibiotic-susceptible strains: Acinetobacter baumannii ATCC 19606, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 35923; multidrug-resistant strains: A. baumannii ATCC BAA-1797, E. coli BAA-196, P. aeruginosa ATCC BAA-2108 and S. aureus ATCC 43300. Initial minimum inhibition concentration (MIC) results showed the Cu(II) complexes Cu(SB4CB) 2 and Cu(SBFH) 2 , demonstrated obvious antibacterial activity as compared to the ligand alone. Fractional inhibitory concentration (FIC) index showed improved MIC values with additivity and synergistic effect for Cu(SBFH) 2 in combination with POLY and PAβN. From the in silico molecular docking investigation, Cu(SBFH) 2 was shown to engage in hydrophobic interactions via its phenyl rings with surrounding hydrophobic residues in the binding pocket of S. aureus NorA, E. coli AcrB, P. aeruginosa MexB and A. baumannii AdeB efflux pumps. The phenyl rings of the ligand could also form π-π stacking with adjacent residues in the binding site of A. baumannii AdeB. Besides, hydrogen bonding and π-cation interactions were also observed via the carboxyl group, hydroxyl group and phenyl ring of SBFH moiety, respectively with nearby residues in the E. coli AcrB binding pocket. This study indicates that the combination strategy of Cu(SBFH) 2 with POLY and PAβN enhances therapeutic potential and sheds light on the binding pockets inside bacteria efflux pumps and the binding interactions of ligand in the binding site.</description><identifier>ISSN: 1573-3149</identifier><identifier>EISSN: 1573-3904</identifier><identifier>DOI: 10.1007/s10989-021-10358-x</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Advances in peptide therapeutics ; Animal Anatomy ; Antibacterial activity ; Antibiotics ; Antimicrobial peptides ; Bacteria ; Binding sites ; Biochemistry ; Biomedical and Life Sciences ; E coli ; Escherichia coli ; Gram-negative bacteria ; Histology ; Hydrogen bonding ; Hydrophobicity ; Life Sciences ; Ligands ; Minimum inhibitory concentration ; Molecular Medicine ; Morphology ; Multidrug resistance ; Multidrug resistant organisms ; p-Hydroxybenzoic acid ; Pharmaceutical Sciences/Technology ; Pharmacology/Toxicology ; Phenylalanine ; Polymer Sciences ; Polymyxin B ; Polymyxins ; Staphylococcus aureus ; Strains (organisms)</subject><ispartof>International journal of peptide research and therapeutics, 2022-03, Vol.28 (2), Article 60</ispartof><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2022</rights><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c319t-de40c4dabdef4cf40e1ae15209126854d72a0c0d48270d0708d5748585c3c04a3</citedby><cites>FETCH-LOGICAL-c319t-de40c4dabdef4cf40e1ae15209126854d72a0c0d48270d0708d5748585c3c04a3</cites><orcidid>0000-0003-4321-0684</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10989-021-10358-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10989-021-10358-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Gan, Wei Khang</creatorcontrib><creatorcontrib>Liew, Hui Shan</creatorcontrib><creatorcontrib>Pua, Lesley Jia Wei</creatorcontrib><creatorcontrib>Ng, Xiao Ying</creatorcontrib><creatorcontrib>Fong, Kar Wai</creatorcontrib><creatorcontrib>Cheong, Siew Lee</creatorcontrib><creatorcontrib>Liew, Yun Khoon</creatorcontrib><creatorcontrib>Low, May Lee</creatorcontrib><title>Novel Cu(II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains</title><title>International journal of peptide research and therapeutics</title><addtitle>Int J Pept Res Ther</addtitle><description>Concerns on increasing trends of multidrug resistance (MDR) around the world have triggered the need to investigate and develop new therapeutic strategies and potent antibacterial drugs. Polymyxins, a class of polycationic antimicrobial peptides, have been regarded as the last-line therapy against Gram-negative bacteria due to limited new antibiotics and phenylalanine-arginine β-naphthylamide (PAβN), a peptidomimetic compound has been characterised as an efflux pump inhibitor (EPI) that have been investigated to overcome efflux-mediated multidrug resistance. In this work, the antibacterial activity of two Schiff base ligands derived from the condensation of S-benzyl dithiocarbazate with 4-carboxybenzaldehye (SB4CB) and 4-formyl-3-hydroxybenzoic acid (SBFH) their copper(II) complexes (Cu(SB4CB) 2 and Cu(SBFH) 2 ) were tested individually, and the most promising compound was tested in combination with polymyxin B (POLY) and PAβN against different bacteria, such as antibiotic-susceptible strains: Acinetobacter baumannii ATCC 19606, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 35923; multidrug-resistant strains: A. baumannii ATCC BAA-1797, E. coli BAA-196, P. aeruginosa ATCC BAA-2108 and S. aureus ATCC 43300. Initial minimum inhibition concentration (MIC) results showed the Cu(II) complexes Cu(SB4CB) 2 and Cu(SBFH) 2 , demonstrated obvious antibacterial activity as compared to the ligand alone. Fractional inhibitory concentration (FIC) index showed improved MIC values with additivity and synergistic effect for Cu(SBFH) 2 in combination with POLY and PAβN. From the in silico molecular docking investigation, Cu(SBFH) 2 was shown to engage in hydrophobic interactions via its phenyl rings with surrounding hydrophobic residues in the binding pocket of S. aureus NorA, E. coli AcrB, P. aeruginosa MexB and A. baumannii AdeB efflux pumps. The phenyl rings of the ligand could also form π-π stacking with adjacent residues in the binding site of A. baumannii AdeB. Besides, hydrogen bonding and π-cation interactions were also observed via the carboxyl group, hydroxyl group and phenyl ring of SBFH moiety, respectively with nearby residues in the E. coli AcrB binding pocket. This study indicates that the combination strategy of Cu(SBFH) 2 with POLY and PAβN enhances therapeutic potential and sheds light on the binding pockets inside bacteria efflux pumps and the binding interactions of ligand in the binding site.</description><subject>Advances in peptide therapeutics</subject><subject>Animal Anatomy</subject><subject>Antibacterial activity</subject><subject>Antibiotics</subject><subject>Antimicrobial peptides</subject><subject>Bacteria</subject><subject>Binding sites</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>E coli</subject><subject>Escherichia coli</subject><subject>Gram-negative bacteria</subject><subject>Histology</subject><subject>Hydrogen bonding</subject><subject>Hydrophobicity</subject><subject>Life Sciences</subject><subject>Ligands</subject><subject>Minimum inhibitory concentration</subject><subject>Molecular Medicine</subject><subject>Morphology</subject><subject>Multidrug resistance</subject><subject>Multidrug resistant organisms</subject><subject>p-Hydroxybenzoic acid</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Pharmacology/Toxicology</subject><subject>Phenylalanine</subject><subject>Polymer Sciences</subject><subject>Polymyxin B</subject><subject>Polymyxins</subject><subject>Staphylococcus aureus</subject><subject>Strains (organisms)</subject><issn>1573-3149</issn><issn>1573-3904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9UN1OwjAYXYwmIvoCXjXxRi8qX7uObpdA_CEhSIJ625SuYyWjw3YoewLfxwfxmRxO451X5yTnLzlBcE7gmgDwnieQxAkGSjCBMIrx7iDokIiHOEyAHf5ywpLj4MT7FUBEOYFO8D4tX3WBRtvL8fgKzVVusgwNpddoVK43hd7tcWGsrExp0ZupcjQri3pd74xFw94s17YuZCGtsRoP3NLsCfr8wFO5yau80dYm1WiwlMb6Cj1LZ8qtbxZUpZ2RBZpXbi-dBkeZLLw--8Fu8HR78zi6x5OHu_FoMMEqJEmFU81AsVQuUp0xlTHQRGoSUUgI7ccRSzmVoCBlMeWQAoc4jTiLozhSoQImw25w0fZuXPmy1b4Sq3LrbDMpaJ_SPo-hzxsXbV3Kld47nYmNM2vpakFA7A8X7eGiOVx8Hy52TShsQ74x26V2f9X_pL4AM-SFzA</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Gan, Wei Khang</creator><creator>Liew, Hui Shan</creator><creator>Pua, Lesley Jia Wei</creator><creator>Ng, Xiao Ying</creator><creator>Fong, Kar Wai</creator><creator>Cheong, Siew Lee</creator><creator>Liew, Yun Khoon</creator><creator>Low, May Lee</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><orcidid>https://orcid.org/0000-0003-4321-0684</orcidid></search><sort><creationdate>20220301</creationdate><title>Novel Cu(II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains</title><author>Gan, Wei Khang ; Liew, Hui Shan ; Pua, Lesley Jia Wei ; Ng, Xiao Ying ; Fong, Kar Wai ; Cheong, Siew Lee ; Liew, Yun Khoon ; Low, May Lee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319t-de40c4dabdef4cf40e1ae15209126854d72a0c0d48270d0708d5748585c3c04a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Advances in peptide therapeutics</topic><topic>Animal Anatomy</topic><topic>Antibacterial activity</topic><topic>Antibiotics</topic><topic>Antimicrobial peptides</topic><topic>Bacteria</topic><topic>Binding sites</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>E coli</topic><topic>Escherichia coli</topic><topic>Gram-negative bacteria</topic><topic>Histology</topic><topic>Hydrogen bonding</topic><topic>Hydrophobicity</topic><topic>Life Sciences</topic><topic>Ligands</topic><topic>Minimum inhibitory concentration</topic><topic>Molecular Medicine</topic><topic>Morphology</topic><topic>Multidrug resistance</topic><topic>Multidrug resistant organisms</topic><topic>p-Hydroxybenzoic acid</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Pharmacology/Toxicology</topic><topic>Phenylalanine</topic><topic>Polymer Sciences</topic><topic>Polymyxin B</topic><topic>Polymyxins</topic><topic>Staphylococcus aureus</topic><topic>Strains (organisms)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gan, Wei Khang</creatorcontrib><creatorcontrib>Liew, Hui Shan</creatorcontrib><creatorcontrib>Pua, Lesley Jia Wei</creatorcontrib><creatorcontrib>Ng, Xiao Ying</creatorcontrib><creatorcontrib>Fong, Kar Wai</creatorcontrib><creatorcontrib>Cheong, Siew Lee</creatorcontrib><creatorcontrib>Liew, Yun Khoon</creatorcontrib><creatorcontrib>Low, May Lee</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>International journal of peptide research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gan, Wei Khang</au><au>Liew, Hui Shan</au><au>Pua, Lesley Jia Wei</au><au>Ng, Xiao Ying</au><au>Fong, Kar Wai</au><au>Cheong, Siew Lee</au><au>Liew, Yun Khoon</au><au>Low, May Lee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Cu(II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains</atitle><jtitle>International journal of peptide research and therapeutics</jtitle><stitle>Int J Pept Res Ther</stitle><date>2022-03-01</date><risdate>2022</risdate><volume>28</volume><issue>2</issue><artnum>60</artnum><issn>1573-3149</issn><eissn>1573-3904</eissn><abstract>Concerns on increasing trends of multidrug resistance (MDR) around the world have triggered the need to investigate and develop new therapeutic strategies and potent antibacterial drugs. Polymyxins, a class of polycationic antimicrobial peptides, have been regarded as the last-line therapy against Gram-negative bacteria due to limited new antibiotics and phenylalanine-arginine β-naphthylamide (PAβN), a peptidomimetic compound has been characterised as an efflux pump inhibitor (EPI) that have been investigated to overcome efflux-mediated multidrug resistance. In this work, the antibacterial activity of two Schiff base ligands derived from the condensation of S-benzyl dithiocarbazate with 4-carboxybenzaldehye (SB4CB) and 4-formyl-3-hydroxybenzoic acid (SBFH) their copper(II) complexes (Cu(SB4CB) 2 and Cu(SBFH) 2 ) were tested individually, and the most promising compound was tested in combination with polymyxin B (POLY) and PAβN against different bacteria, such as antibiotic-susceptible strains: Acinetobacter baumannii ATCC 19606, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 35923; multidrug-resistant strains: A. baumannii ATCC BAA-1797, E. coli BAA-196, P. aeruginosa ATCC BAA-2108 and S. aureus ATCC 43300. Initial minimum inhibition concentration (MIC) results showed the Cu(II) complexes Cu(SB4CB) 2 and Cu(SBFH) 2 , demonstrated obvious antibacterial activity as compared to the ligand alone. Fractional inhibitory concentration (FIC) index showed improved MIC values with additivity and synergistic effect for Cu(SBFH) 2 in combination with POLY and PAβN. From the in silico molecular docking investigation, Cu(SBFH) 2 was shown to engage in hydrophobic interactions via its phenyl rings with surrounding hydrophobic residues in the binding pocket of S. aureus NorA, E. coli AcrB, P. aeruginosa MexB and A. baumannii AdeB efflux pumps. The phenyl rings of the ligand could also form π-π stacking with adjacent residues in the binding site of A. baumannii AdeB. Besides, hydrogen bonding and π-cation interactions were also observed via the carboxyl group, hydroxyl group and phenyl ring of SBFH moiety, respectively with nearby residues in the E. coli AcrB binding pocket. This study indicates that the combination strategy of Cu(SBFH) 2 with POLY and PAβN enhances therapeutic potential and sheds light on the binding pockets inside bacteria efflux pumps and the binding interactions of ligand in the binding site.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s10989-021-10358-x</doi><orcidid>https://orcid.org/0000-0003-4321-0684</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1573-3149
ispartof International journal of peptide research and therapeutics, 2022-03, Vol.28 (2), Article 60
issn 1573-3149
1573-3904
language eng
recordid cdi_proquest_journals_2622678067
source SpringerLink Journals - AutoHoldings
subjects Advances in peptide therapeutics
Animal Anatomy
Antibacterial activity
Antibiotics
Antimicrobial peptides
Bacteria
Binding sites
Biochemistry
Biomedical and Life Sciences
E coli
Escherichia coli
Gram-negative bacteria
Histology
Hydrogen bonding
Hydrophobicity
Life Sciences
Ligands
Minimum inhibitory concentration
Molecular Medicine
Morphology
Multidrug resistance
Multidrug resistant organisms
p-Hydroxybenzoic acid
Pharmaceutical Sciences/Technology
Pharmacology/Toxicology
Phenylalanine
Polymer Sciences
Polymyxin B
Polymyxins
Staphylococcus aureus
Strains (organisms)
title Novel Cu(II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T05%3A55%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Cu(II)%20Schiff%20Base%20Complex%20Combination%20with%20Polymyxin%20B/Phenylalanine-Arginine%20%CE%B2-Naphthylamide%20Against%20Various%20Bacterial%20Strains&rft.jtitle=International%20journal%20of%20peptide%20research%20and%20therapeutics&rft.au=Gan,%20Wei%20Khang&rft.date=2022-03-01&rft.volume=28&rft.issue=2&rft.artnum=60&rft.issn=1573-3149&rft.eissn=1573-3904&rft_id=info:doi/10.1007/s10989-021-10358-x&rft_dat=%3Cproquest_cross%3E2622678067%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2622678067&rft_id=info:pmid/&rfr_iscdi=true